Shaanxi hongji pharmaceutical co., LTD  Powered by www.300.cn   

陕ICP备14006455号-1

NEWS

Shaanxi Food and Drug Administration as well as the deputy director general and other research groups went to Hongji Pharmaceutical

Author:
Source:
2015/05/29 14:28
Page view:
[Abstract]:
In the morning of May 27, the Shaanxi Food and Drug Administration accompanied by the deputy director and deputy inspector Mr. Zhang, as well as other supervisors came down to our production base to c
  On the morning of May 27, the food and drug administration of shaanxi province, accompanied by the deputy director and deputy inspector zhang, came down to our production base to conduct research and give important work guidance.
 
 
The picture shows the President of hongji pharmaceutical group to introduce the group's development plan according to the group plan
 
 
The picture shows the research group and President of hongji pharmaceutical co., LTD exchanging views on the development status of health care products industry
 
  In the process of research,research group first ask for details of my company's current development situation,listened to the President for the current main product research and development progress of the work report,which our company with great concentration was developed and on the market in recent ten years for treatment of disease of heart head blood-vessel products"hin glands capsule",the product has won"the food health G20150388"batch number,and cooperation with the leaders to discuss the NEC extraction of natto Portuguese excitation mold for the important efficacy of thrombolysis lipid-lowering,talked about the batch number application and several other major products of the company issued.
 
  At the same time,the President emphasized that hongji pharmaceutical has always put the strict extraction of product materials and quality control in the first place,and is committed to making hongji pharmaceutical an excellent health care product enterprise in shaanxi province and even the whole country.
 
 
The picture shows vice director ying and his delegation visiting the soft capsule production workshop of the pharmaceutical factory
 
  After hearing the report, the research team visited the production workshop of the pharmaceutical factory under the guidance of the staff of the pharmaceutical factory. The President of the company introduced the strict automatic production equipment of the soft capsule production room, tablet pressing room, laboratory and sample retention room to the research group in detail.
 
 
 
The picture shows a delegation of vice director ying visiting the sample room of the pharmaceutical factory to exchange samples of major products
 
 
  After the visit, the deputy director of the research group should give full recognition to the size and strict management system of hongji pharmaceutical factory, and emphasize that the enterprise should strictly control product positioning, advertising and quality management, and believe that it should actively support the large-scale development of high-quality and strict health care products enterprises.